BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gall B, Yee A, Berry B, Bircham D, Hayashi A, Dansereau J, Hart J. Rituximab for management of refractory pregnancy-associated immune thrombocytopenic purpura. J Obstet Gynaecol Can 2010;32:1167-71. [PMID: 21176329 DOI: 10.1016/S1701-2163(16)34741-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Busse M, Campe KJ, Nowak D, Schumacher A, Plenagl S, Langwisch S, Tiegs G, Reinhold A, Zenclussen AC. IL-10 producing B cells rescue mouse fetuses from inflammation-driven fetal death and are able to modulate T cell immune responses. Sci Rep 2019;9:9335. [PMID: 31249364 DOI: 10.1038/s41598-019-45860-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
2 Das G, Damotte V, Gelfand JM, Bevan C, Cree BAC, Do L, Green AJ, Hauser SL, Bove R. Rituximab before and during pregnancy: A systematic review, and a case series in MS and NMOSD. Neurol Neuroimmunol Neuroinflamm 2018;5:e453. [PMID: 29564373 DOI: 10.1212/NXI.0000000000000453] [Cited by in Crossref: 88] [Cited by in F6Publishing: 35] [Article Influence: 22.0] [Reference Citation Analysis]
3 Sica A, Vitiello P, Papa A, Calogero A, Sagnelli C, Casale D, Mottola M, Svanera G, Dodaro CA, Martinelli E, Troiani T, Ciardiello F, Casale B. Use of Rituximab in NHL Malt Type Pregnant in I° Trimester for Two Times. Open Med (Wars) 2019;14:757-60. [PMID: 31844674 DOI: 10.1515/med-2019-0087] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
4 Prakash J, Ganiger VC. Acute Kidney Injury in Pregnancy-specific Disorders. Indian J Nephrol 2017;27:258-70. [PMID: 28761227 DOI: 10.4103/0971-4065.202406] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 3.2] [Reference Citation Analysis]
5 Nguyen TG, Ward CM, Morris JM. To B or not to B cells-mediate a healthy start to life. Clin Exp Immunol 2013;171:124-34. [PMID: 23286939 DOI: 10.1111/cei.12001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
6 Deshayes S, Mahévas M, Godeau B. Rituximab and immune thrombocytopenia in adults: The state of knowledge 20 years later. Rev Med Interne 2021;42:32-7. [PMID: 32680716 DOI: 10.1016/j.revmed.2020.05.016] [Reference Citation Analysis]
7 Donohoe F, Higgins M, Higgins S, McAuliffe F, Murphy K. Rituximab - A novel therapy for severe ITP in pregnancy: A case report. Obstet Med 2019;12:196-8. [PMID: 31853261 DOI: 10.1177/1753495X18778489] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Mormile I, Granata F, Punziano A, de Paulis A, Rossi FW. Immunosuppressive Treatment in Antiphospholipid Syndrome: Is It Worth It? Biomedicines 2021;9:132. [PMID: 33535377 DOI: 10.3390/biomedicines9020132] [Reference Citation Analysis]